Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
HLA-B7-Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis.
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
FTY720 mediates activation suppression and G(0)/G (1) cell cycle arrest in a concanavalin A-induced mouse lymphocyte pan-activation model.
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.
Switching to Gilenya® (fingolimod) from a standard interferon offers sustained freedom from disease activity for people with relapsing remitting multiple sclerosis
Venocentric Lesions: An MRI Marker of MS?
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
The validity and reliability of the neurogenic bladder symptom score (NBSS).
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.
Multiple sclerosis and pregnancy: maternal considerations.
Daily hassles reported by Dutch multiple sclerosis patients.
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis.
A culture system to study oligodendrocyte myelination processes using engineered nanofibers.
The best basic science paper in multiple sclerosis in 2014: Important role for the choroid plexus in the central nervous system entry of leukocytes.
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain.
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.
Prediction of response to interferon therapy in multiple sclerosis.
Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease.
Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain.
Pain and multiple sclerosis: pathophysiology and treatment.
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.
MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.
Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.
Pages
« first
‹ previous
…
201
202
203
204
205
206
207
208
209
…
next ›
last »